About Us
Who We Are
INVITRO is one of Russia's largest and leading private medical groups, specializing in laboratory diagnostics and comprehensive medical care. Founded in 1995 by a physician, the company pioneered the private laboratory diagnostics market in Russia .
Our Mission and Values
Our core philosophy is centered on unwavering commitment to quality, speed, and convenience. We believe healthcare should be simple, fast, and accessible for everyone. This commitment is reflected in our new brand slogan: "The result is confidence" (В результате – уверенность). We strive to provide patients and physicians with certainty in diagnosis and treatment choices through reliable and accurate medical services .
Our Operations and Reach
Today, INVITRO operates one of the largest networks of medical offices, with over 1,930 locations across 5 countries, including Russia, Belarus, Kazakhstan, Kyrgyzstan, and Armenia . Our advanced infrastructure includes 7 state-of-the-art laboratory complexes that perform more than 194,000 tests daily . We are supported by a team of over 15,450 employees, including more than 1,190 physicians, serving over 17 million patients annually .
Services: We offer a broad spectrum of over 1,500 types of laboratory tests, from simple to highly complex analyses, as well as instrumental diagnostics (ultrasound, ECG), consultations with doctors of key specializations, and house call services .
Quality Assurance: INVITRO is renowned for its adherence to international quality standards. We are one of the few laboratories in the world to have been certified multiple times under the rigorous "Six Sigma" quality management program by Westgard QC, confirming an exceptionally low error rate in our analyses .
Franchising: Our franchise program is a long-standing leader in national ratings, enabling the opening of over 700 medical offices under the INVITRO brand across Russia .
Innovation and Evolution
INVITRO is evolving beyond a laboratory. We are actively expanding our network of multi-specialty clinics and investing heavily in MedTech and digital services. This includes developing mobile applications, launching proprietary health products, and creating online services for health monitoring, making it more convenient for patients to manage their health .